Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
出版年份 2021 全文链接
标题
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 176, Issue -, Pages 1-12
出版商
Elsevier BV
发表日期
2021-02-05
DOI
10.1016/j.ijbiomac.2021.02.012
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
- (2020) David S. Hui et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Nature-derived compounds modulating Wnt/β-catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases
- (2020) G. Sferrazza et al. Acta Pharmaceutica Sinica B
- Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19)
- (2020) Leyin Zhang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
- (2020) Olga Abian et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
- (2020) Marta Menegazzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer
- (2020) Saleh A. Almatroodi et al. MOLECULES
- Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
- (2020) Ruocong Yang et al. PHARMACOLOGICAL RESEARCH
- The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
- (2020) Dan Zhang et al. PHARMACOLOGICAL RESEARCH
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Bioactive natural compounds against human coronaviruses: a review and perspective
- (2020) Yanfang Xian et al. Acta Pharmaceutica Sinica B
- Accelerated preclinical paths to support rapid development of COVID-19 therapeutics
- (2020) Jay A. Grobler et al. Cell Host & Microbe
- Roles of flavonoids against coronavirus infection
- (2020) Maria Russo et al. CHEMICO-BIOLOGICAL INTERACTIONS
- COVID-19 update: The race to therapeutic development
- (2020) Julianne D. Twomey et al. DRUG RESISTANCE UPDATES
- Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro
- (2020) Minsu Jang et al. Evidence-based Complementary and Alternative Medicine
- A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
- (2020) Magnus Nakrem Lyngbakken et al. Nature Communications
- Current Prevention of COVID-19: Natural Products and Herbal Medicine
- (2020) Junqing Huang et al. Frontiers in Pharmacology
- Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
- (2020) Jie Fang et al. Frontiers in Pharmacology
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
- (2020) Xiaofei Chen et al. Acta Pharmaceutica Sinica B
- Recent Advances in the Understanding of the Health Benefits and Molecular Mechanisms Associated with Green Tea Polyphenols
- (2019) Lujuan Xing et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Ultra-large library docking for discovering new chemotypes
- (2019) Jiankun Lyu et al. NATURE
- Protective effect of green tea catechin against urban fine dust particle-induced skin aging by regulation of NF-κB, AP-1, and MAPKs signaling pathways
- (2019) Lei Wang et al. ENVIRONMENTAL POLLUTION
- Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review
- (2018) Muhammad Akram et al. PHYTOTHERAPY RESEARCH
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Looking for protein stabilizing drugs with thermal shift assay
- (2015) Giuseppina Andreotti et al. Drug Testing and Analysis
- Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- (2014) Liang Dong et al. Evidence-based Complementary and Alternative Medicine
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
- (2014) Rolf Hilgenfeld FEBS Journal
- Direct interaction of natural and synthetic catechins with signal transducer activator of transcription 1 affects both its phosphorylation and activity
- (2013) Marta Menegazzi et al. FEBS Journal
- The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease
- (2013) Zhilin Ren et al. Protein & Cell
- Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
- (2012) Thi Thanh Hanh Nguyen et al. BIOTECHNOLOGY LETTERS
- Activation and maturation of SARS-CoV main protease
- (2011) Bin Xia et al. Protein & Cell
- Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition
- (2010) Young Bae Ryu et al. BIOORGANIC & MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started